Treatment of Cutaneous Larva Migrans
The first-line treatment for cutaneous larva migrans is either ivermectin 200 μg/kg as a single oral dose or albendazole 400 mg once daily for 3 days. 1
Clinical Presentation and Diagnosis
- Cutaneous larva migrans presents with a characteristic self-limiting itchy, serpiginous rash that migrates at 1-2 cm per day, caused by penetration of skin by dog/cat hookworm larvae 1
- The condition has a worldwide distribution with predominance in warmer regions 1
- Diagnosis is primarily clinical, based on the characteristic appearance of the rash 1, 2
- The condition may be associated with eosinophilia in some cases 1, 2
Treatment Options
First-line Treatment
Comparative Efficacy
- A randomized trial showed that a single dose of ivermectin (12 mg) had a significantly higher cure rate (100%) compared to a single dose of albendazole (400 mg) with a cure rate of only 46% 4
- For multiple or diffuse lesions, some evidence suggests a longer course of albendazole (400 mg daily for 7 days) may be beneficial to reduce recurrence 5
Treatment Algorithm
Confirm diagnosis based on characteristic serpiginous, itchy rash and history of exposure to potentially contaminated soil 1, 2
Choose treatment based on availability and patient factors:
For severe or extensive disease:
For secondary bacterial infection:
- Add appropriate antibiotics to address superinfection caused by scratching 7
Monitoring and Follow-up
- Most cases resolve completely within one week of appropriate treatment 6
- If symptoms persist after initial treatment, consider:
Prevention
- Regular treatment of dogs and cats with anthelmintic drugs 7
- Avoid direct skin contact with potentially contaminated soil 7
- Proper hand hygiene after contact with dogs or soil potentially contaminated with dog feces 2